VANCOUVER, B.C. and WARMINSTER, Pa., Feb. 22, 2018 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading hepatitis B virus (HBV) therapeutic solutions company, today announcedREAD MORE…
Introducing our new Sports-Health Alliance.
We develop award-winning PR programs that are at the intersection of health, medicine, and sports. We call on our cadre of athletes, broadcasters and sports business leaders with whom we have close relationships and share the passions of our clients
Learn more about how this strategic approach is shifting perceptions of our clients and their products, fueling their clinical trial enrollment, and doing much, much more